MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
KAPA — Kairos Pharma, Ltd.
NYSE AmericanKairos Pharma, Ltd.
$1.55
-0.01(-0.64%)
- O
- 1.55
- H
- 1.59
- L
- 1.52
- V
- 18.98K
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About KAPA
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateSep 16, 2024
Employees1
Stock ExchangeNYSE American
Ticker SymbolKAPA
Websitehttps://www.kairospharma.com
Key Financial Statistics
| Market Cap | $5.28M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.27 - $2.11 |
| 52-Week Avg Volume | 756.9K |
| VWAP | $1.56 |
| Transactions | 382 |
| Total Recorded Bars | 515 days |